Apogee Therapeutics Inc. (APGE)
undefined
undefined%
At close: undefined
45.00
1.65%
After-hours Dec 13, 2024, 04:41 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22
Net Income -83.98M -39.78M
Depreciation & Amortization - -
Stock-Based Compensation 6.10M 2.14M
Other Working Capital 4.49M 9.40M
Other Non-Cash Items -2.98M 11.40M
Deferred Income Tax - -
Change in Working Capital 6.11M 9.81M
Operating Cash Flow -74.76M -16.43M
Capital Expenditures -167.00K -
Acquisitions - -
Purchase of Investments -303.74M -
Sales Maturities Of Investments 30.00M -
Other Investing Acitivies - -
Investing Cash Flow -273.91M -
Debt Repayment - -
Common Stock Repurchased - -
Dividend Paid - -
Other Financial Acitivies - 168.50M
Financial Cash Flow 315.39M 183.62K
Net Cash Flow -33.28M -16.24M
Free Cash Flow -74.93M -16.43M